Login to myESAIC Membership


The ESAIC is dedicated to supporting professionals in anaesthesiology and intensive care by serving as the hub for development and dissemination of valuable educational, scientific, research, and networking resources.



The ESAIC hosts the Euroanaesthesia and Focus Meeting congresses that serve as platforms for cutting-edge science and innovation in the field. These events bring together experts, foster networking, and facilitate knowledge exchange in anaesthesiology, intensive care, pain management, and perioperative medicine. Euroanaesthesia is one of the world’s largest and most influential scientific congresses for anaesthesia professionals. Held annually throughout Europe, our congress is a contemporary event geared towards education, knowledge exchange and innovation in anaesthesia, intensive care, pain and perioperative medicine, as well as a platform for immense international visibility for scientific research.


Professional Growth

The ESAIC's mission is to foster and provide exceptional training and educational opportunities. The ESAIC ensures the provision of robust and standardised examination and certification systems to support the professional development of anaesthesiologists and to ensure outstanding future doctors in the field of anaesthesiology and intensive care.



The ESAIC aims to advance patient outcomes and contribute to the progress of anaesthesiology and intensive care evidence-based practice through research. The ESAIC Clinical Trial Network (CTN), the Academic Contract Research Organisation (A-CRO), the Research Groups and Grants all contribute to the knowledge and clinical advances in the peri-operative setting.

Learn more about the ESAIC Clinical Trial Network (CTN) and the associated studies.


EU Projects

The ESAIC is actively involved as a consortium member in numerous EU funded projects. Together with healthcare leaders and practitioners, the ESAIC's involvement as an EU project partner is another way that it is improving patient outcomes and ensuring the best care for every patient.


Patient Safety

The ESAIC aims to promote the professional role of anaesthesiologists and intensive care physicians and enhance perioperative patient outcomes by focusing on quality of care and patient safety strategies. The Society is committed to implementing the Helsinki Declaration and leading patient safety projects.



To ESAIC is committed to implementing the Glasgow Declaration and drive initiatives towards greater environmental sustainability across anaesthesiology and intensive care in Europe.



The ESAIC works in collaboration with industry, national societies, and specialist societies to promote advancements in anaesthesia and intensive care. The Industry Partnership offers visibility and engagement opportunities for industry participants with ESAIC members, facilitating understanding of specific needs in anaesthesiology and in intensive care. This partnership provides resources for education and avenues for collaborative projects enhancing science, education, and patient safety. The Specialist Societies contribute to high-quality educational opportunities for European anaesthesiologists and intensivists, fostering discussion and sharing, while the National Societies, through NASC, maintain standards, promote events and courses, and facilitate connections. All partnerships collectively drive dialogue, learning, and growth in the anaesthesiology and intensive care sector.



Guidelines play a crucial role in delivering evidence-based recommendations to healthcare professionals. Within the fields of anaesthesia and intensive care, guidelines are instrumental in standardizing clinical practices and enhancing patient outcomes. For many years, the ESAIC has served as a pivotal platform for facilitating continuous advancements, improving care standards and harmonising clinical management practices across Europe.



With over 40 years of publication history, the EJA (European Journal of Anaesthesiology) has established itself as a highly respected and influential journal in its field. It covers a wide range of topics related to anaesthesiology and intensive care medicine, including perioperative medicine, pain management, critical care, resuscitation, and patient safety.



Becoming a member of ESAIC implies becoming a part of a vibrant community of nearly 8,000 professionals who exchange best practices and stay updated on the latest developments in anaesthesiology, intensive care and perioperative medicine. ESAIC membership equips you with the tools and resources necessary to enhance your daily professional routine, nurture your career growth, and play an active role in advancing anaesthesiology, intensive care and perioperative medicine.

Membership opportunities
at the ESAIC

Newsletter 2021

Newsletter April 2021: The NECTARINE study

Nicola Disma



The results of NECTARINE, a CTN granted in 2015 by ESAIC, are finally published in the British Journal of Anaesthesia. Two sister publications, both on the principal outcome, have been accepted for publication in the BJA: one on critical events and risk factors, the second on difficult tracheal intubation.

NECTARINE CTN is a prospective, observational, international cohort study on neonatal and infant anaesthesia. It was designed to determine the incidence of interventions performed in response to a list of predetermined severe critical events occurring during anaesthesia. Neonates and infants included in NECTARINE  were followed for 90 days after anaesthesia for morbidity and mortality.

165 centres from 31 countries took part in the NECTARINE CTN collecting data on 5609 patients undergoing 6542 procedures. The mean age of the included patients was 2 months of life, with an average weight of 4 kg. Results highlighted that one-third of children undergoing anaesthesia needed a treatment to correct at least one severe critical event, with cardiovascular instability being the most frequently reported. Afterwards, one or more complications were observed in about 16% of these patients during the 30 days of follow-up, and the overall mortality during the 90 days of follow-up was 3.2%.

NECTARINE represents the first large dataset focused on a very fragile population: neonates and infants up to the age of 60 post-menstrual weeks (around 5 months of age) undergoing anaesthesia. This is a special population, known to be at increased risk for perioperative complications and high morbidity and mortality. Nectarine shed the light on specific risk factors predicting the occurrence of complications during and after anaesthesia.

NECTARINE CTN represents another achievement for the paediatric anaesthesia community in Europe, after the APRICOT CTN. It has been a very long journey between the time the protocol was granted by ESAIC in 2015 and the time of publication in 2021. This is due to several reasons. First of all, having all the participating centres ready for recruitment after obtaining their local IRB/Ethics approval took about one year, and then the recruitment window of 3 months was opened in 2016. Then, the following two years were spent on two rounds of data cleaning, a huge and complex task. In 2019 the database was ready and exported for statistical analysis, and results interpreted for publication. However, when the manuscript was ready for submission, the Covid-19 pandemic was at its peak and resulted in difficulties in getting the study published as all Journals gave priority to manuscripts related to the pandemic. However, thanks to our perseverance and the help of our statistician (K. Virag) the main article is ready for publication in 2021 in the British Journal of Anaesthesia.

As principal investigators of the NECTARINE CTN,  we learned several lessons, some beyond the scope of pure science. First, to get a multicentre and international study published was a big challenge, with opportunities and difficulties encountered on the way. They were times of enthusiasm when many centres accepted to be part of the network or the expected sample of 5,000 patients was achieved and even exceeded. Second, it was frustrating to spend months cleaning the data and prepare the database for statistics. The lessons learned will help to improve the design of future studies. However, the mission remained always the same: provide new evidence that can improve the quality and safety of neonatal and paediatric anaesthesia.

Despite the long journey, NECTARINE represents another enormous success. With APRICOT first and Nectarine immediately after, the Paediatric Anaesthesia Research Network is well established and can serve as a base for future collaborations. The Network is accessible to anyone interested in running a project on a large scale, and it represents a priceless resource.

Thank you all for the hard work and congratulations to all the Investigators for making this project another great success.


Read our Monthly newsletter.

Read More of our special newsletter covering our virtual congress.

Visit our COVID-19 Resource Hub for other news and resources.